Essayer OR - Gratuit
Disclosure, but still no aliens
Business Standard
|November 29, 2025
The Age of Disclosure arrives during a period of acute public interest in unidentified anomalous phenomena (UAPs), met by predictably cautious official pronouncements.
Director Dan Farah, steeped in the cinematic mythology of E.T. and The X-Files from his growing up years in the 80s and ‘90s, presents his documentary not as conspiratorial froth but as a compilation of testimony from insiders who suggest the United States has quietly accumulated decades of information, and potentially material, suggesting nonhuman intelligence.
Mr Farah has stacked his cast with serious operators. The documentary pulls in 34 contributors, a mix of Congressional figures and longtime national security officers whose job descriptions usually keep them far from speculation. ‘Their presence gives the film an air of institutional weight that conspiracy fare normally lacks.
Jay Stratton, former director of the Pentagon's UAP Task Force, appears on camera to declare that he has seen with his eyes “nonhuman craft and nonhuman beings”. Eric Davis recalls the Soviet recovery of humanoid bodies in 1989. And Marco Rubio, US Secretary of State, warns that UAP intelligence is so tightly compartmentalised that “much of it is restricted even from presidents.”
In an era where every minor mishap is filmed in high definition grainy UFO videos have lost their sting. But those with decades of top-level security clearances are considerably harder to dismiss.
Cette histoire est tirée de l'édition November 29, 2025 de Business Standard.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Business Standard
Business Standard
Nalco urges Odisha govt to expedite land handover process for ‘30K cr projects
Navratna central public-sector enterprise (CPSE) Nalco has requested the Odisha government to expedite the land handover process for its 30,000 crore expansion projects that will boost capacity and help it achieve the Maharatna status by 2030.
1 mins
March 10, 2026
Business Standard
Women-led startups saw 9% funding drop in 2025
Female labour participation just 42%, among lowest in G20: Axis Bank study
3 mins
March 10, 2026
Business Standard
How India can kick the West Asian oil habit
Increasing the use of alternative fuels like ethanol could be one way out
6 mins
March 10, 2026
Business Standard
India’s T20 WC win brings new stars to brand crease
\"Sachin Tendulkar carried Indian cricket on his shoulders for 21 years.
3 mins
March 10, 2026
Business Standard
UBS downgrades OMCs as oil crosses $100/bbl
The recent rally in crude prices and refining margins create a sense of déjà vu, UBS said, mirroring the 2022 oil market disruption.
1 min
March 10, 2026
Business Standard
LIC drove 18% rise in life insurers’ NBP in Feb
New business premium of life insurance companies grew 18 per cent year-on-year (Y-o-Y) to ₹35,417 crore in February, driven by robust growth at the state-owned Life Insurance Corporation of India (LIC) due to a favourable base.
1 mins
March 10, 2026
Business Standard
Why India needs Russian oil
India's oil security is becoming increasingly fragile. Over 80 per cent of its crude imports come from just two suppliers — West Asia and Russia — both now facing geopolitical stress. In this environment, resuming full purchases of Russian oil may not be a choice but a necessity. Here are eight reasons why.
3 mins
March 10, 2026
Business Standard
India, Uzbekistan launch pharma-nutra corridor
India and Uzbekistan on Monday launched a structured pharmaceutical and nutraceutical trade corridor aimed at expanding access to the Commonwealth of Independent States (CIS) and the wider Eurasian healthcare market, estimated at $7-10 billion.
1 min
March 10, 2026
Business Standard
A clear derating
Markets risk underperformance if we don’t regain our growth credentials
5 mins
March 10, 2026
Business Standard
Delhi HC allows Dr Reddy’s to make semaglutide for export
A division Bench of the Delhi High Court on Monday affirmed a single-judge Bench’s order allowing pharmaceutical company Dr Reddy’s Laboratories to manufacture the diabetes and weight-management drug semaglutide in India for export to jurisdictions where Danish drugmaker Novo Nordisk does not have patent protection.
2 mins
March 10, 2026
Listen
Translate
Change font size
